Schaaf, Hendrik Simon Willemse, Marianne Cilliers, Karien Labadarios, Demetre Maritz, Johannes Stephanus Hussey, Gregory D. McIlleron, Helen Smith, Peter Donald, Peter Roderick
(2009-04)
Background: Rifampin is a key drug in antituberculosis chemotherapy because it rapidly kills the majority of bacilli in tuberculosis lesions, prevents relapse and thus enables 6-month short-course chemotherapy. Little is ...